FindTrial
Sign In

The study of serum Nesfatin-1, IL-26 and IL-6 in patients with exacerbation of acne before menstruation

The study of serum Nesfatin-1, IL-26 and IL-6 in patients with exacerbation of acne before menstruation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-ROC-17010384
Enrollment
Unknown
Registered
2017-01-11
Start date
2017-02-15
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

acne

Interventions

Two groups:NA

Sponsors

Department of Dermatology, Affiliated Hospital of Jiangsu University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
16 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Aged <50 years old female acne patients; 2. No obvious signs and symptoms of infection, or laboratory tests without evidence of infection; 3. No contraceptive use.

Exclusion criteria

Exclusion criteria: 1. The patients systematically used tetracycline and other antibiotics, isotretinoin, corticosteroids and immunosuppressive agents affect systemic immune function drugs 1 months before treatment; 2. The patients exclude dermatomyositis, psoriasis, rheumatoid arthritis and other autoimmune diseases and other allergic diseases.

Design outcomes

Primary

MeasureTime frame
Nesfatin-1;IL-26;—

Countries

China

Contacts

Public ContactLi Yumei

Jiangsu University

l.yumei@aliyun.com+86 13914569541

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026